Week 106 Review - Massive increase in Optibiotix holding

What an exciting week! The big headline was selling half my IQE:IQE shares in order to take advantage of the crazy dip in OPTI:Optibiotix. I'm happy to say it's paying off so far. Total portfolio value has smashed through previous records by £3,000 to hit £71,166. The profit-taking did immediately put my paper profits down by nearly £5,000 but by the end of the week the difference between cost price and value was only £1,853 down, so well over half had been clawed back. The combined portfolios are back in the black, with a small buffer of £1,057.

Worst performer this week was IQE:IQE, suffering from profit taking (including me!) and dropping 11% in my ISA, but who cares when it's still 323% up?

It's with unparalleled joy that I can say the best performer this week was OPTI:Optibiotix. My ISA holding increased by 8%, but thanks to buying a massive chunk at 59.95p, my SIPP holding climbed in value by 16%. I now hold 43,960 shares across three accounts costing £29,779 and currently losing £2,120. However, that's half what it was losing last week and each 1p rise is now worth £439. If it gets to 100p a share I'll be sitting on £14,000 profit and that's only my very short term target. When shares in SBTX:SkinBiotherapeutics get distributed and hopefully Sweetbiotix further down the line, the compounding could be spectacular.

Staying in the black was a priority and it just about worked.

The ISA and share accounts looks like this

			Weekly Change
Portfolio cost	£46,796.25		+£0
Portfolio sell value (bid price - commission)	£47,223.98	(+0.9%)	+£1,240.53
Potential profits	£7,679.96		-£77.44
Yr 3 Dividends	£0		+£0
Yr 3 Profit from sales	£549.25		+£0
Yr 3 Average monthly cash profit	£1,092.51	(28%)	-£1,092.51
Total Dividends	£1,179.05		+£0
Total Profit from sales	£7,261.74		+£0
Average monthly cash profit	£340.76	(8.7%)	-£3.24
(Sold stocks profit + Dividends - Fees / Months)

Very interesting - potential profits are down £77 thanks to the drop in IQE:IQE but small increases elsewhere limited the damage. Most of the £1,240 increase is thanks to OPTI:Optibiotix. Year 3 projected performance is skewed horribly by selling GVC:GVC Holdings in week 1, so that will come tumbling down every week now. Overall performance slips a tiny amount and although 8.7% is below target, it's not so bad I'm worrying.

 Up and down like a yo-yo

The SIPP looks like this after week 90

			Weekly Change
Portfolio cost	£22,828.63		+£4,975.63
Portfolio sell value (bid price - commission)	£23,615.68	(3.4%)	-£3,093.73
Potential profits	£2,144.25		-£4,100.60
Yr 2 Dividends	£294.96		+£0
Yr 2 Profit from sales	£6,575.33		+£4,978.52
Yr 2 Average monthly cash profit	£775.900	(40.8%)	+£562.10
Total Dividends	£708.15		+£0
Total Profit from sales	£8,925.19		+£4,978.52
Average monthly cash profit	£458.20	(24.1%)	+£237.25
(Sold stocks profit + Dividends - Fees / Months)

Where to start? The £4,978 increase in realised profits came from selling IQE:IQE and that massively boosted my average performance by over 100% to £458 per month (24.1%). This was immediately re-invested mainly in OPTI:Optibiotix but also CAML:Central Asia Metals, both of which had decent rises this week.

Although potential profits declined by £4,100 that actually means an £875 improvement when you remove the sale mainly thanks to CAML:Central Asia Metals. Even better than that, the sell value is only down by £3,093 having taken into account the increase in cost, which means around £1,900 of the damage inflicted by the sale has been clawed back, mainly through reducing OPTI:Optibiotix losses. All in all very satisfying.

What a spike! I really didn't expect to stay in the black, so very very happy with this.

The trading account looks like this after week 56

			Weekly Change
Portfolio cost	£486.05		+£0
Cash	£79.63		+£0
Portfolio sell value (bid price - commission)	£327.21	(-32.7%)	+£0
Potential profits	£0		+£0
Dividends	£1.15		+£0
Profit from sales	-£22.85		+£0
Average monthly cash profit	-£1.68	(-4.2%)	+£0.03
(Sold stocks profit + Dividends - Fees / Months)

No change at all - not even worth talking about

Ditto

I have a bit of a dilemma with IQE:IQE now. I actually wanted to buy more, but ended up halving my holding. The timing was good as there has been a drop-off, but with the iPhone 8 about to launch and interims on 5th September, the drop could be short lived.

I do have a few options. In my standard share account, BDEV:Barratt Developments is only losing £16.75 if you include the dividends so I could liberate £600 for a small chunk of IQE:IQE. I also have £1,800 worth of KIBO:KIBO Mining in my share account which is in profit, but I wanted to hold those for free KAT:Katoro Gold shares. The question is, how much higher risk is an African coal mine compared to a Welsh semi-conductor manufacturer? Quite a lot I think. I still have over £2,000 KIBO:Kibo Mining in my ISA so would maintain an interest.

The other big possibility is LOOK:Lookers which has never recovered from Brexit and is still losing £800. However this is trading on a P/E ratio of 5 which is crazy. I could liberate £1,200 but not sure I can stomach such a big loss on a good company which will surely re-rate soon.

Let's see what next week brings...